Bioanalytical Services
 |
PharmaNet offers bioanalytical laboratory services through its subsidiaries: Anapharm, Anapharm Europe, Keystone Analytical and Taylor Technology.
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
Together, they offer over 1000 bioanalytical validated methods for one or more analytes from human or animal matrices.
Our laboratories can develop and validate custom (or project-specific) ELISAs or ligand-binding assays and can also develop and validate cell-based assays.
We are also actively working on developing proprietary methods that are not currently included in this list.
You may also view our list of biomarkers below.
List of BioMarkers
(Click here)
Contact us for more details.
(In alphabetically order)
 |
 |
 |
 |
 |
| Nabumetone; 6-methoxy-2-naphtaleneacetic acid | Pain | HPLC/FLR | 50-50000 ng/mL | Human EDTA Plasma |
| Naftidrofuryl | Cardiovascular | HPLC/FLR | 5-1000 ng/mL | Human EDTA Plasma |
| Naftifine | Infectious Disease | LC/MS/MS | 1-1000 ng/mL | Human Plasma |
| Naftifine | Infectious Disease | LC/MS/MS | 1-1000 ng/mL | Human Urine |
| Naloxone; 6-Beta-Hydroxy-Naloxol | Pain | LC/MS/MS | 5-500 pg/mL | Human Plasma |
| Naltrexone | Central Nervous System Agents | LC/MS/MS | 1-100 ng/mL | Human Plasma |
| Naltrexone; 6ß-naltrexol | Central Nervous System Agents | LC/MS/MS | 1-100 ng/mL | Human Plasma |
| Naproxen | Pain | HPLC/FLR | 1-100 µg/mL | Human EDTA Plasma |
| Naratriptan | Pain | LC/MS/MS | 50-25000 pg/mL | Human Plasma |
| Nateglinide | Endocrinology | LC/MS/MS | 50-20000 ng/mL | Human EDTA Plasma |
| Nebivolol | Cardiovascular | LC/MS/MS | 20-2500 pg/mL | Human EDTA Plasma |
| Nefazodone; Hydroxy Nefazodone and M-chlorophenylpiperazin | Central Nervous System Agents | LC/MS/MS | 2-500 ng/mL ; 0.4-100 ng/mL | Human EDTA Plasma |
| Nevirapine | Infectious Disease | LC/MS/MS | 30-3000 ng/mL | Human EDTA Plasma |
| Niacin | Cardiovascular | LC/MS/MS | 25-10000 ng/mL | Human EDTA Plasma |
| Niacin;Nicotinuric acid | Cardiovascular | LC/MS/MS | 25-10000 ng/mL for both | Human Plasma |
| Nicorandil | Cardiovascular | LC/MS/MS | 0.5-200 ng/mL | Human EDTA Plasma |
| Nicotine | Autonomic Drugs | LC/MS/MS | 1-100 ng/mL | Human Sodium Heparin Plasma |
| Nicotine metabolite: Cotinine | Autonomic Drugs | LC/MS/MS | 10-100 ng/mL | Human Plasma |
| Nifedipine | Cardiovascular | LC/MS/MS | 5-1000 ng/mL | Rat Plasma |
| Nifedipine | Cardiovascular | LC/MS/MS | 0.5-250 ng/mL | Human EDTA Plasma |
| Nifedipine | Cardiovascular | LC/MS/MS | 0.5-100 ng/mL | Human EDTA K2 Plasma |
| Nimesulide | Pain, Rheumatology | LC/MS | 50-10000 ng/mL | Human EDTA Plasma |
| Nitrofurantoin | TBD | LC/MS/MS | 1-1000 ng/mL | Human EDTA Plasma |
| Nizatidine and N-2-monodesmethylnizatidine | Gastrointestinal | HPLC/UV | 10-5000 ng/mL ; 5-2500 ng/mL | Human EDTA Plasma |
| Nomegestrol | Endocrinology | LC/MS/MS | 0.2-20 ng/mL | Human Plasma |
| Nomegestrol Acetate | Endocrinology | LC/MS/MS | 50-20000 pg/mL | Human EDTA Plasma |
| Norethindrone | Endocrinology | GC/MS/MS | 50-25000 pg/mL | Human Serum |
| Norethindrone | Endocrinology | LC/MS/MS | 100-50000 pg/mL | Human EDTA Plasma |
| Norgestimate; 17-deacetyl norgestimate and Levonorgestrel | Endocrinology | LC/MS/MS | 100-5000 ng/mL; 50-3000 pg/mL | Human EDTA Plasma |
| Nortriptyline; E-10-hydroxy nortriptyline | Central Nervous System Agents | LC/MS/MS | 1-200 ng/mL | Human EDTA Plasma |